

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | interferon-gamma production (GO:0032609) | 7.36797320 |
| 2 | negative regulation of cell killing (GO:0031342) | 7.31994452 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.31994452 |
| 4 | negative T cell selection (GO:0043383) | 6.72465059 |
| 5 | negative thymic T cell selection (GO:0045060) | 6.52914674 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.48502081 |
| 7 | positive thymic T cell selection (GO:0045059) | 6.38589904 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 5.97863120 |
| 9 | response to interleukin-15 (GO:0070672) | 5.90177985 |
| 10 | positive T cell selection (GO:0043368) | 5.89195124 |
| 11 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.86094354 |
| 12 | tolerance induction (GO:0002507) | 5.66060973 |
| 13 | thymic T cell selection (GO:0045061) | 5.62327087 |
| 14 | T cell migration (GO:0072678) | 5.55689202 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.31217165 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.19134595 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.19134595 |
| 18 | T cell selection (GO:0045058) | 5.17416397 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 5.08998236 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.81566192 |
| 21 | negative regulation of T cell mediated immunity (GO:0002710) | 4.80878330 |
| 22 | leukocyte aggregation (GO:0070486) | 4.77929388 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.43844323 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 4.43354060 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.38519502 |
| 26 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.20968457 |
| 27 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.20968457 |
| 28 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.19604253 |
| 29 | positive regulation of isotype switching (GO:0045830) | 4.19102356 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14754573 |
| 31 | T cell receptor signaling pathway (GO:0050852) | 4.12917120 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.08594559 |
| 33 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.07002690 |
| 34 | response to muramyl dipeptide (GO:0032495) | 4.01932889 |
| 35 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.00442172 |
| 36 | regulation of cell killing (GO:0031341) | 3.94100033 |
| 37 | activated T cell proliferation (GO:0050798) | 3.92214175 |
| 38 | T cell costimulation (GO:0031295) | 3.91967278 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.87544699 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.87544699 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.87544699 |
| 42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.87544699 |
| 43 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.87544699 |
| 44 | modulation by symbiont of host immune response (GO:0052553) | 3.87544699 |
| 45 | lymphocyte costimulation (GO:0031294) | 3.85693373 |
| 46 | positive regulation of DNA recombination (GO:0045911) | 3.80910856 |
| 47 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.79101419 |
| 48 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.79101419 |
| 49 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.76608485 |
| 50 | positive regulation of cell killing (GO:0031343) | 3.70594445 |
| 51 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.69964953 |
| 52 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.68673645 |
| 53 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.67728225 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.64829859 |
| 55 | positive regulation of tolerance induction (GO:0002645) | 3.64503512 |
| 56 | detection of other organism (GO:0098543) | 3.64437084 |
| 57 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.63122773 |
| 58 | positive regulation of B cell mediated immunity (GO:0002714) | 3.63122773 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 3.62876859 |
| 60 | positive regulation of interleukin-17 production (GO:0032740) | 3.62656900 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.61602848 |
| 62 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.59797479 |
| 63 | regulation of activation of Janus kinase activity (GO:0010533) | 3.59739426 |
| 64 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58365892 |
| 65 | regulation of isotype switching (GO:0045191) | 3.58025548 |
| 66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.54862014 |
| 67 | cellular response to type I interferon (GO:0071357) | 3.51717693 |
| 68 | type I interferon signaling pathway (GO:0060337) | 3.51717693 |
| 69 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.49600067 |
| 70 | response to type I interferon (GO:0034340) | 3.49016720 |
| 71 | leukocyte cell-cell adhesion (GO:0007159) | 3.47413175 |
| 72 | detection of bacterium (GO:0016045) | 3.44293829 |
| 73 | regulation of memory T cell differentiation (GO:0043380) | 3.43906644 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.43587629 |
| 75 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.43587629 |
| 76 | lymphocyte migration (GO:0072676) | 3.41257830 |
| 77 | defense response to protozoan (GO:0042832) | 3.40279210 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.39824565 |
| 79 | mast cell activation (GO:0045576) | 3.37904461 |
| 80 | neutrophil activation involved in immune response (GO:0002283) | 3.37599370 |
| 81 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.36964024 |
| 82 | regulation of tolerance induction (GO:0002643) | 3.35980287 |
| 83 | surfactant homeostasis (GO:0043129) | 3.33822152 |
| 84 | positive regulation of humoral immune response (GO:0002922) | 3.31947540 |
| 85 | * alpha-beta T cell activation (GO:0046631) | 3.30660608 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.26450464 |
| 87 | * T cell differentiation (GO:0030217) | 3.26439895 |
| 88 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.26347806 |
| 89 | * alpha-beta T cell differentiation (GO:0046632) | 3.25882019 |
| 90 | positive regulation of T cell mediated immunity (GO:0002711) | 3.25819816 |
| 91 | neutrophil activation (GO:0042119) | 3.24900090 |
| 92 | positive regulation of defense response to virus by host (GO:0002230) | 3.24172132 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 3.24097547 |
| 94 | positive regulation of interleukin-2 production (GO:0032743) | 3.22459755 |
| 95 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.21930174 |
| 96 | regulation of T cell mediated immunity (GO:0002709) | 3.21619510 |
| 97 | regulation of regulatory T cell differentiation (GO:0045589) | 3.21566598 |
| 98 | regulation of response to interferon-gamma (GO:0060330) | 3.20403947 |
| 99 | negative regulation of adaptive immune response (GO:0002820) | 3.19660268 |
| 100 | heterotypic cell-cell adhesion (GO:0034113) | 3.18258189 |
| 101 | * natural killer cell activation (GO:0030101) | 3.17361911 |
| 102 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.17205623 |
| 103 | macrophage activation involved in immune response (GO:0002281) | 3.15957289 |
| 104 | regulation of B cell mediated immunity (GO:0002712) | 3.15931743 |
| 105 | detection of external biotic stimulus (GO:0098581) | 3.13452814 |
| 106 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.12290487 |
| 107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11863998 |
| 108 | B cell receptor signaling pathway (GO:0050853) | 3.11809904 |
| 109 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.11035996 |
| 110 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.10876166 |
| 111 | regulation of T-helper 1 type immune response (GO:0002825) | 3.08029928 |
| 112 | regulation of interleukin-17 production (GO:0032660) | 3.07957945 |
| 113 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07403174 |
| 114 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.06739653 |
| 115 | cellular defense response (GO:0006968) | 3.06562177 |
| 116 | response to peptidoglycan (GO:0032494) | 3.05815346 |
| 117 | regulation of chronic inflammatory response (GO:0002676) | 3.05490830 |
| 118 | detection of molecule of bacterial origin (GO:0032490) | 3.03786185 |
| 119 | regulation of germinal center formation (GO:0002634) | 3.03739207 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 3.03368432 |
| 121 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.02286636 |
| 122 | cellular extravasation (GO:0045123) | 3.02179646 |
| 123 | response to protozoan (GO:0001562) | 3.01857079 |
| 124 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.01376925 |
| 125 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.00940394 |
| 126 | * T-helper cell differentiation (GO:0042093) | 3.00165670 |
| 127 | * CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.00165670 |
| 128 | germinal center formation (GO:0002467) | 3.00077100 |
| 129 | response to interferon-alpha (GO:0035455) | 2.99447978 |
| 130 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.98412313 |
| 131 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94658637 |
| 132 | * T cell activation involved in immune response (GO:0002286) | 2.93705279 |
| 133 | regulation of mast cell degranulation (GO:0043304) | 2.93627794 |
| 134 | negative regulation of innate immune response (GO:0045824) | 2.91046523 |
| 135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90618671 |
| 136 | * T cell activation (GO:0042110) | 2.90486021 |
| 137 | regulation of mast cell activation (GO:0033003) | 2.89783360 |
| 138 | regulation of interleukin-2 production (GO:0032663) | 2.88696633 |
| 139 | * alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.88219863 |
| 140 | * alpha-beta T cell activation involved in immune response (GO:0002287) | 2.88219863 |
| 141 | * T cell differentiation involved in immune response (GO:0002292) | 2.88219863 |
| 142 | granulocyte activation (GO:0036230) | 2.88008501 |
| 143 | positive regulation of interferon-alpha production (GO:0032727) | 2.87981215 |
| 144 | dendritic cell migration (GO:0036336) | 2.84538530 |
| 145 | positive regulation of immunoglobulin production (GO:0002639) | 2.83662805 |
| 146 | myeloid dendritic cell activation (GO:0001773) | 2.83597409 |
| 147 | T cell proliferation (GO:0042098) | 2.81833080 |
| 148 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.79399772 |
| 149 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.78901919 |
| 150 | lymph node development (GO:0048535) | 2.78389053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.39803089 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.04600007 |
| 3 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.46448598 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.20365775 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.96377855 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.89658087 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.79853748 |
| 8 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.63081554 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.61618857 |
| 10 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.58389660 |
| 11 | * MYB_26560356_Chip-Seq_TH2_Human | 3.10292113 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.87469870 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.73253466 |
| 14 | MYB_26560356_Chip-Seq_TH1_Human | 2.61414895 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.48101735 |
| 16 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41900180 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32867235 |
| 18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.32261917 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.24392963 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.23364599 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21346472 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.20316195 |
| 23 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.11690680 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.10586348 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.07140411 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05102398 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.04652269 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94116173 |
| 29 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91965611 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87756016 |
| 31 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.86256742 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77385522 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74672115 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64677057 |
| 35 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.63162104 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.54500521 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48033319 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45745924 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42000887 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39720235 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38079970 |
| 42 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36300831 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34116805 |
| 44 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.30019211 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27126411 |
| 46 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.26999412 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26509328 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26447874 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26197845 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24602326 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23724742 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13346858 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11258503 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09295691 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08937106 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07816401 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06866116 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06476639 |
| 59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04696238 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04408313 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03406922 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03188078 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02761077 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02198097 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00300637 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99027432 |
| 67 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.98985929 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98463348 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97877926 |
| 70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96919930 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95070455 |
| 72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94409158 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93636994 |
| 74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93477444 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91732165 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90995342 |
| 77 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90573618 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89491610 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88474364 |
| 80 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87963131 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87276050 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.87276050 |
| 83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86356900 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86346457 |
| 85 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85798005 |
| 86 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.85708211 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85539989 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84206466 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83812284 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83181752 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83019754 |
| 92 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81212621 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81205103 |
| 94 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80698270 |
| 95 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.79772121 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79113595 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78789705 |
| 98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78433249 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78368477 |
| 100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78296453 |
| 101 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.76714383 |
| 102 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76449202 |
| 103 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74464267 |
| 104 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.72633856 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.72600335 |
| 106 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.71816487 |
| 107 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71396523 |
| 108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71084478 |
| 109 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70809910 |
| 110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70808084 |
| 111 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70321919 |
| 112 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69776287 |
| 113 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.69277448 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.68889888 |
| 115 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.68188922 |
| 116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.68006626 |
| 117 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.67383259 |
| 118 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.66231204 |
| 119 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.64724997 |
| 120 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.64375009 |
| 121 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63770627 |
| 122 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.63613417 |
| 123 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.62566699 |
| 124 | CJUN_26792858_Chip-Seq_BT549_Human | 0.62383532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.58858486 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.57221775 |
| 3 | MP0000685_abnormal_immune_system | 3.56155346 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.39567004 |
| 5 | MP0001790_abnormal_immune_system | 3.16204339 |
| 6 | MP0005387_immune_system_phenotype | 3.16204339 |
| 7 | MP0009785_altered_susceptibility_to | 3.08853797 |
| 8 | MP0001800_abnormal_humoral_immune | 2.93234144 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.78070817 |
| 10 | MP0006082_CNS_inflammation | 2.77728097 |
| 11 | MP0003724_increased_susceptibility_to | 2.70701948 |
| 12 | MP0001873_stomach_inflammation | 2.67490279 |
| 13 | * MP0002723_abnormal_immune_serum | 2.67384616 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.65834441 |
| 15 | * MP0001819_abnormal_immune_cell | 2.64579566 |
| 16 | MP0002405_respiratory_system_inflammati | 2.64486793 |
| 17 | MP0004782_abnormal_surfactant_physiolog | 2.52729135 |
| 18 | MP0005025_abnormal_response_to | 2.47407658 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.45755078 |
| 20 | MP0003436_decreased_susceptibility_to | 2.33261361 |
| 21 | MP0002398_abnormal_bone_marrow | 2.32470943 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.28521640 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.26183783 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.20853626 |
| 25 | MP0000716_abnormal_immune_system | 2.17732801 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.11812946 |
| 27 | MP0002132_abnormal_respiratory_system | 2.11673496 |
| 28 | MP0002006_tumorigenesis | 2.11555167 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 2.08255187 |
| 30 | MP0000703_abnormal_thymus_morphology | 2.03182382 |
| 31 | MP0002419_abnormal_innate_immunity | 2.01438255 |
| 32 | MP0003866_abnormal_defecation | 2.00793502 |
| 33 | MP0004947_skin_inflammation | 1.99734123 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.96085513 |
| 35 | MP0002722_abnormal_immune_system | 1.85135840 |
| 36 | MP0000858_altered_metastatic_potential | 1.80139882 |
| 37 | MP0003448_altered_tumor_morphology | 1.70434449 |
| 38 | MP0002429_abnormal_blood_cell | 1.70283388 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.69223474 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.66939931 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.65554033 |
| 42 | MP0002933_joint_inflammation | 1.63594039 |
| 43 | MP0004510_myositis | 1.59952704 |
| 44 | MP0005310_abnormal_salivary_gland | 1.58930925 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.57493546 |
| 46 | MP0001851_eye_inflammation | 1.56471222 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.46727593 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.45545883 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.45519749 |
| 50 | MP0002009_preneoplasia | 1.35810276 |
| 51 | MP0001853_heart_inflammation | 1.34259120 |
| 52 | MP0004381_abnormal_hair_follicle | 1.32333726 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.29657203 |
| 54 | MP0000490_abnormal_crypts_of | 1.22957163 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.20056662 |
| 56 | MP0008260_abnormal_autophagy | 1.13818986 |
| 57 | MP0003303_peritoneal_inflammation | 1.11437835 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.09313723 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.07669975 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.07669975 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.06399968 |
| 62 | MP0003045_fibrosis | 1.05762523 |
| 63 | MP0008469_abnormal_protein_level | 1.03549119 |
| 64 | MP0002254_reproductive_system_inflammat | 0.99732173 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 0.99046800 |
| 66 | MP0004883_abnormal_blood_vessel | 0.98752629 |
| 67 | MP0009764_decreased_sensitivity_to | 0.95235715 |
| 68 | MP0008995_early_reproductive_senescence | 0.95183213 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 0.90860066 |
| 70 | MP0000604_amyloidosis | 0.89897258 |
| 71 | MP0008004_abnormal_stomach_pH | 0.89022143 |
| 72 | MP0003075_altered_response_to | 0.87115985 |
| 73 | MP0005164_abnormal_response_to | 0.85765402 |
| 74 | MP0001881_abnormal_mammary_gland | 0.85488106 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.85043285 |
| 76 | MP0000566_synostosis | 0.83350804 |
| 77 | MP0001216_abnormal_epidermal_layer | 0.80415436 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 0.80025159 |
| 79 | MP0008961_abnormal_basal_metabolism | 0.78742221 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.77470572 |
| 81 | MP0001958_emphysema | 0.77305981 |
| 82 | MP0005451_abnormal_body_composition | 0.76792490 |
| 83 | MP0001663_abnormal_digestive_system | 0.72657602 |
| 84 | MP0000343_altered_response_to | 0.72437607 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.71192534 |
| 86 | MP0003828_pulmonary_edema | 0.67009778 |
| 87 | MP0005166_decreased_susceptibility_to | 0.64214891 |
| 88 | MP0005023_abnormal_wound_healing | 0.63855977 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.63332173 |
| 90 | MP0001346_abnormal_lacrimal_gland | 0.63321578 |
| 91 | MP0003795_abnormal_bone_structure | 0.63084568 |
| 92 | MP0003252_abnormal_bile_duct | 0.62266617 |
| 93 | MP0000609_abnormal_liver_physiology | 0.60884095 |
| 94 | MP0009840_abnormal_foam_cell | 0.60734869 |
| 95 | MP0000249_abnormal_blood_vessel | 0.60668193 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.60518558 |
| 97 | MP0001849_ear_inflammation | 0.60133998 |
| 98 | MP0000627_abnormal_mammary_gland | 0.59518129 |
| 99 | MP0005174_abnormal_tail_pigmentation | 0.59213719 |
| 100 | MP0001191_abnormal_skin_condition | 0.58241448 |
| 101 | MP0009278_abnormal_bone_marrow | 0.58201417 |
| 102 | MP0010307_abnormal_tumor_latency | 0.58001480 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.56221586 |
| 104 | MP0001501_abnormal_sleep_pattern | 0.56213624 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.55195194 |
| 106 | MP0000383_abnormal_hair_follicle | 0.54997873 |
| 107 | MP0005388_respiratory_system_phenotype | 0.54778877 |
| 108 | MP0002133_abnormal_respiratory_system | 0.54778877 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.54359426 |
| 110 | MP0002163_abnormal_gland_morphology | 0.54272040 |
| 111 | MP0009763_increased_sensitivity_to | 0.53424533 |
| 112 | MP0003091_abnormal_cell_migration | 0.53409793 |
| 113 | MP0005390_skeleton_phenotype | 0.52895423 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.52514471 |
| 115 | MP0008007_abnormal_cellular_replicative | 0.49966898 |
| 116 | MP0003787_abnormal_imprinting | 0.49266430 |
| 117 | MP0004484_altered_response_of | 0.48833392 |
| 118 | MP0000477_abnormal_intestine_morphology | 0.47611509 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.47151291 |
| 120 | MP0001243_abnormal_dermal_layer | 0.46876489 |
| 121 | MP0003195_calcinosis | 0.46625646 |
| 122 | MP0005083_abnormal_biliary_tract | 0.46501698 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.43783552 |
| 124 | MP0000367_abnormal_coat/_hair | 0.43411727 |
| 125 | MP0003690_abnormal_glial_cell | 0.42795567 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.42724152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retrobulbar optic neuritis (HP:0100654) | 6.42465513 |
| 2 | Optic neuritis (HP:0100653) | 6.42465513 |
| 3 | Myositis (HP:0100614) | 5.90005217 |
| 4 | T lymphocytopenia (HP:0005403) | 5.67351023 |
| 5 | Orchitis (HP:0100796) | 5.62914272 |
| 6 | Abnormality of T cell number (HP:0011839) | 5.56449380 |
| 7 | Keratoconjunctivitis (HP:0001096) | 4.36239985 |
| 8 | Nasal polyposis (HP:0100582) | 4.29116467 |
| 9 | Keratoconjunctivitis sicca (HP:0001097) | 4.28265263 |
| 10 | Abnormality of T cells (HP:0002843) | 4.14669924 |
| 11 | Interstitial pulmonary disease (HP:0006530) | 3.97363258 |
| 12 | IgM deficiency (HP:0002850) | 3.95748706 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 3.95333278 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.93997429 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.89646770 |
| 16 | Chronic otitis media (HP:0000389) | 3.83273825 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.80874539 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.74777151 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.74777151 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.72510565 |
| 21 | Severe combined immunodeficiency (HP:0004430) | 3.72142403 |
| 22 | Pustule (HP:0200039) | 3.58507347 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.54744965 |
| 24 | Abnormality of the fingertips (HP:0001211) | 3.53709733 |
| 25 | Hemoptysis (HP:0002105) | 3.51104130 |
| 26 | Arterial thrombosis (HP:0004420) | 3.42816338 |
| 27 | Stomatitis (HP:0010280) | 3.42291637 |
| 28 | Encephalitis (HP:0002383) | 3.41882961 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.41209131 |
| 30 | Vasculitis (HP:0002633) | 3.37590727 |
| 31 | Combined immunodeficiency (HP:0005387) | 3.29100821 |
| 32 | Chronic diarrhea (HP:0002028) | 3.15736413 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.10519046 |
| 34 | Joint swelling (HP:0001386) | 3.09806680 |
| 35 | IgG deficiency (HP:0004315) | 3.07905103 |
| 36 | Meningitis (HP:0001287) | 3.07608173 |
| 37 | Abnormality of eosinophils (HP:0001879) | 3.05682794 |
| 38 | Stomach cancer (HP:0012126) | 2.93717105 |
| 39 | Recurrent viral infections (HP:0004429) | 2.90392521 |
| 40 | Thyroiditis (HP:0100646) | 2.86382338 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 2.83487785 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.77759785 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 2.77192441 |
| 44 | Increased IgE level (HP:0003212) | 2.75188256 |
| 45 | Bronchitis (HP:0012387) | 2.74699320 |
| 46 | Increased IgM level (HP:0003496) | 2.73678448 |
| 47 | Premature loss of primary teeth (HP:0006323) | 2.72920295 |
| 48 | Gangrene (HP:0100758) | 2.71594349 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.67259305 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 2.66418357 |
| 51 | Eosinophilia (HP:0001880) | 2.65528305 |
| 52 | Keratitis (HP:0000491) | 2.64064514 |
| 53 | Pulmonary embolism (HP:0002204) | 2.63339566 |
| 54 | Leukocytosis (HP:0001974) | 2.63300036 |
| 55 | Lymphopenia (HP:0001888) | 2.61120663 |
| 56 | IgA deficiency (HP:0002720) | 2.59701162 |
| 57 | Urticaria (HP:0001025) | 2.52260525 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.50687489 |
| 59 | B lymphocytopenia (HP:0010976) | 2.49301700 |
| 60 | Abnormality of B cell number (HP:0010975) | 2.49301700 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49241652 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.42925391 |
| 63 | Cheilitis (HP:0100825) | 2.39359346 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.38169782 |
| 65 | Hypochromic anemia (HP:0001931) | 2.36622058 |
| 66 | Increased density of long bones (HP:0006392) | 2.35975854 |
| 67 | Persistence of primary teeth (HP:0006335) | 2.33168082 |
| 68 | Anorexia (HP:0002039) | 2.31280682 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.29678378 |
| 70 | Obstructive lung disease (HP:0006536) | 2.27478256 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27478256 |
| 72 | Recurrent skin infections (HP:0001581) | 2.26902005 |
| 73 | Granulocytopenia (HP:0001913) | 2.22081017 |
| 74 | Episodic fever (HP:0001954) | 2.18497042 |
| 75 | Vertigo (HP:0002321) | 2.17741178 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.17257211 |
| 77 | Abnormality of macrophages (HP:0004311) | 2.16779719 |
| 78 | Peritonitis (HP:0002586) | 2.16139657 |
| 79 | Abnormality of the prostate (HP:0008775) | 2.15858313 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.15185391 |
| 81 | Glomerulopathy (HP:0100820) | 2.14057954 |
| 82 | Recurrent sinusitis (HP:0011108) | 2.13926918 |
| 83 | Osteomyelitis (HP:0002754) | 2.12078356 |
| 84 | Lip pit (HP:0100267) | 2.11913598 |
| 85 | Sepsis (HP:0100806) | 2.10263494 |
| 86 | Anhidrosis (HP:0000970) | 2.07762928 |
| 87 | Abnormality of the endocardium (HP:0004306) | 2.06327608 |
| 88 | Bronchiectasis (HP:0002110) | 2.04877304 |
| 89 | Lymphoma (HP:0002665) | 2.03587277 |
| 90 | Chronic sinusitis (HP:0011109) | 2.02543312 |
| 91 | Recurrent bacterial skin infections (HP:0005406) | 2.01575719 |
| 92 | Acute hepatic failure (HP:0006554) | 2.01346672 |
| 93 | Hypochromic microcytic anemia (HP:0004840) | 2.00958160 |
| 94 | Abnormality of the pleura (HP:0002103) | 2.00927403 |
| 95 | Skin rash (HP:0000988) | 1.99895120 |
| 96 | Epistaxis (HP:0000421) | 1.99711693 |
| 97 | Gastrointestinal inflammation (HP:0004386) | 1.98177546 |
| 98 | Periodontitis (HP:0000704) | 1.96659664 |
| 99 | Agammaglobulinemia (HP:0004432) | 1.89296526 |
| 100 | Ureteral stenosis (HP:0000071) | 1.88620218 |
| 101 | Prostate neoplasm (HP:0100787) | 1.87215975 |
| 102 | Polyneuropathy (HP:0001271) | 1.87036026 |
| 103 | Thrombophlebitis (HP:0004418) | 1.86892132 |
| 104 | Arthralgia (HP:0002829) | 1.84961268 |
| 105 | Alveolar cell carcinoma (HP:0006519) | 1.82649356 |
| 106 | Abnormality of the pericardium (HP:0001697) | 1.80436565 |
| 107 | Ureteral obstruction (HP:0006000) | 1.79444103 |
| 108 | Acne (HP:0001061) | 1.79036244 |
| 109 | Chest pain (HP:0100749) | 1.76933818 |
| 110 | Gingivitis (HP:0000230) | 1.76038569 |
| 111 | Skin ulcer (HP:0200042) | 1.74920577 |
| 112 | Hyperactive renin-angiotensin system (HP:0000841) | 1.74507936 |
| 113 | Aseptic necrosis (HP:0010885) | 1.74133558 |
| 114 | Gingival bleeding (HP:0000225) | 1.73915608 |
| 115 | Gastrointestinal stroma tumor (HP:0100723) | 1.72455058 |
| 116 | Hypoplasia of the thymus (HP:0000778) | 1.68445147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.53729924 |
| 2 | MAP4K1 | 4.37898413 |
| 3 | ITK | 3.38043263 |
| 4 | RIPK4 | 3.36667680 |
| 5 | JAK3 | 2.95137692 |
| 6 | MAP3K14 | 2.89792978 |
| 7 | JAK1 | 2.63412879 |
| 8 | FGFR4 | 2.58067543 |
| 9 | IRAK3 | 2.51570393 |
| 10 | ZAP70 | 2.48201744 |
| 11 | STK10 | 2.47973778 |
| 12 | FGFR3 | 2.28500853 |
| 13 | IKBKE | 2.28352081 |
| 14 | MAP2K2 | 2.24817504 |
| 15 | TYK2 | 2.11206412 |
| 16 | TAOK3 | 2.08148314 |
| 17 | SIK3 | 2.00882857 |
| 18 | TEC | 1.99699150 |
| 19 | NME1 | 1.78781473 |
| 20 | TGFBR2 | 1.77113897 |
| 21 | MST4 | 1.74194050 |
| 22 | NLK | 1.72705956 |
| 23 | EPHA3 | 1.60956832 |
| 24 | CSK | 1.56508511 |
| 25 | TBK1 | 1.53209880 |
| 26 | IRAK4 | 1.51310321 |
| 27 | MATK | 1.47766759 |
| 28 | LCK | 1.44269312 |
| 29 | EPHB1 | 1.43709293 |
| 30 | STK24 | 1.43212969 |
| 31 | IKBKB | 1.42760165 |
| 32 | GRK6 | 1.36475471 |
| 33 | BTK | 1.36119263 |
| 34 | MARK3 | 1.32025533 |
| 35 | CHUK | 1.25463929 |
| 36 | NUAK1 | 1.24813155 |
| 37 | HCK | 1.20700388 |
| 38 | PRKCQ | 1.17241172 |
| 39 | MAP3K13 | 1.16122367 |
| 40 | PIM1 | 1.11873764 |
| 41 | SYK | 1.11373740 |
| 42 | SIK2 | 1.08841169 |
| 43 | CDK12 | 1.04894815 |
| 44 | TNK2 | 1.00906559 |
| 45 | FGR | 0.90881623 |
| 46 | RPS6KA4 | 0.90527666 |
| 47 | FGFR2 | 0.87805159 |
| 48 | ERN1 | 0.87343899 |
| 49 | TRPM7 | 0.87229746 |
| 50 | BLK | 0.87185747 |
| 51 | GRK7 | 0.85191224 |
| 52 | MAP3K12 | 0.83896374 |
| 53 | BRD4 | 0.83895419 |
| 54 | JAK2 | 0.82691590 |
| 55 | TLK1 | 0.82238803 |
| 56 | PRKCH | 0.78324298 |
| 57 | LRRK2 | 0.77635756 |
| 58 | MAP3K7 | 0.74137040 |
| 59 | PDGFRB | 0.73270079 |
| 60 | TSSK6 | 0.72992355 |
| 61 | KIT | 0.72040929 |
| 62 | IRAK1 | 0.71614296 |
| 63 | PIK3CG | 0.68112909 |
| 64 | ACVR1B | 0.67513049 |
| 65 | FES | 0.65905236 |
| 66 | MAPK15 | 0.65739778 |
| 67 | MELK | 0.64725754 |
| 68 | EEF2K | 0.64424698 |
| 69 | RAF1 | 0.64335864 |
| 70 | TESK2 | 0.64317722 |
| 71 | CLK1 | 0.62616690 |
| 72 | DMPK | 0.61376201 |
| 73 | LYN | 0.61072728 |
| 74 | MAP2K6 | 0.55980667 |
| 75 | NEK9 | 0.55752161 |
| 76 | MAP3K6 | 0.55364182 |
| 77 | CDK8 | 0.55351391 |
| 78 | WNK1 | 0.54178976 |
| 79 | CDC42BPA | 0.52257720 |
| 80 | SIK1 | 0.51804076 |
| 81 | KDR | 0.51766901 |
| 82 | PDK1 | 0.50488228 |
| 83 | PTK2B | 0.48581276 |
| 84 | FRK | 0.48240114 |
| 85 | CDK9 | 0.48075983 |
| 86 | CDK6 | 0.47616837 |
| 87 | MAP2K1 | 0.47215250 |
| 88 | RPS6KC1 | 0.46542004 |
| 89 | RPS6KL1 | 0.46542004 |
| 90 | SGK3 | 0.44600928 |
| 91 | PRKD2 | 0.43918166 |
| 92 | KSR2 | 0.43873728 |
| 93 | CDK4 | 0.43624836 |
| 94 | IGF1R | 0.43260466 |
| 95 | MAPK12 | 0.43200497 |
| 96 | ADRBK2 | 0.40628863 |
| 97 | MAPKAPK2 | 0.39866843 |
| 98 | HIPK2 | 0.39494523 |
| 99 | MAP3K3 | 0.36504447 |
| 100 | GRK1 | 0.36409577 |
| 101 | YES1 | 0.34962610 |
| 102 | CDK3 | 0.34054333 |
| 103 | SGK2 | 0.33633379 |
| 104 | PRPF4B | 0.33323012 |
| 105 | TYRO3 | 0.32446544 |
| 106 | RPS6KA2 | 0.31609642 |
| 107 | MAPK7 | 0.30534459 |
| 108 | MAP3K10 | 0.30523351 |
| 109 | TIE1 | 0.30401260 |
| 110 | IRAK2 | 0.30201777 |
| 111 | PTK6 | 0.30049742 |
| 112 | MAP3K5 | 0.29934379 |
| 113 | MAPK4 | 0.29734031 |
| 114 | MAP3K1 | 0.29304975 |
| 115 | RPS6KA5 | 0.29283618 |
| 116 | STK3 | 0.28827609 |
| 117 | EIF2AK2 | 0.28297173 |
| 118 | INSR | 0.27553660 |
| 119 | PRKCD | 0.27268044 |
| 120 | EGFR | 0.26585718 |
| 121 | MARK2 | 0.26530737 |
| 122 | CAMKK2 | 0.25767721 |
| 123 | BMPR2 | 0.24364485 |
| 124 | MAP2K3 | 0.24106236 |
| 125 | STK4 | 0.23697636 |
| 126 | ABL1 | 0.22060039 |
| 127 | FYN | 0.20725155 |
| 128 | GSK3A | 0.19129828 |
| 129 | RPS6KA6 | 0.18304666 |
| 130 | CSF1R | 0.17664404 |
| 131 | MAPK11 | 0.17567273 |
| 132 | MAPK3 | 0.17196811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.23023266 |
| 2 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.73756803 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.35932773 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.99717391 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.89460836 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.69710279 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66203358 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.60643493 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.54334328 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.37113690 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.29053484 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07829687 |
| 13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.99833980 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.99182671 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86050993 |
| 16 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.60569787 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59195081 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56674103 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54901367 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51790597 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47450749 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46719496 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.44599474 |
| 24 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.42842699 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.40576520 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38320093 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33555865 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.30622104 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29151630 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23012489 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.21209801 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.20775192 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18198114 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17393666 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16589939 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11078692 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.06439501 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04724232 |
| 39 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03039333 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02278446 |
| 41 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01286542 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00557627 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99873985 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 0.95367833 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 0.92784309 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 0.87093016 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85358811 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.84386581 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83143644 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.82120240 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81974340 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79828194 |
| 53 | Asthma_Homo sapiens_hsa05310 | 0.79658481 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76619954 |
| 55 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75639444 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 0.75396333 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75317494 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71242530 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70645096 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69982679 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69016077 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.67411741 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66461107 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65699712 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 0.64171695 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.63103962 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62825107 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61931509 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59616061 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57396386 |
| 71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56630404 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56620745 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56039686 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55516229 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54878993 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51962126 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49488493 |
| 78 | Prostate cancer_Homo sapiens_hsa05215 | 0.49461495 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49244483 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48126596 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.47967558 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47308512 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46010134 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44754012 |
| 85 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43501061 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43398907 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43303942 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41448232 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41041313 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40820688 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40648067 |
| 92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39111933 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.38751130 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37367963 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37031151 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34747085 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.31165019 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.29517278 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.27890099 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27107295 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26860749 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26782446 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26642295 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26256645 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26172695 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25070193 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24777534 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24346039 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24222066 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24221728 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24073969 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.24070310 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23728605 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.22664716 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.22374687 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.22113445 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21408083 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18121970 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16222230 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15813757 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13550587 |
| 122 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.09757420 |
| 123 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.09363161 |

